Ritonavir: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
 
imported>David E. Volk
Line 10: Line 10:
== External Links ==
== External Links ==
* {{DailyMed}}
* {{DailyMed}}
* Drug Bank at http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=DB00503.txt
* {{MedMaster}}
* {{DrugBank}}

Revision as of 12:27, 5 March 2008

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
(CC) Image: David E. Volk
Ritonavir

Ritonavir, sold under the brand names Norvir® and Norvir Sec®, and as a mixture with Lopinavir called Kaletra®, is a protease inhibitor used to treat HIV/AIDS by disrupting the reproductive cycle of the virus. Ritonavir binds to and inhibits the HIV-1 viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. Protease inhibitors like ritonavir are almost always used in combination with at least two other anti-HIV drugs.

Its chemical name is 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan- 2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-di(phenyl)hexan- 2-yl]carbamate and its chemical formula is C37H48N6O5S2.

External Links